KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $472,513 | -21.5% | 352,622 | +4.8% | 0.00% | – |
| Q2 2023 | $602,226 | -92.8% | 336,439 | -84.4% | 0.00% | -100.0% |
| Q1 2023 | $8,393,768 | +63.4% | 2,157,781 | +42.8% | 0.00% | 0.0% |
| Q4 2022 | $5,137,965 | +28.6% | 1,511,166 | +106.5% | 0.00% | – |
| Q3 2022 | $3,996,000 | +84.8% | 731,864 | +52.7% | 0.00% | – |
| Q2 2022 | $2,162,000 | -73.7% | 479,418 | -57.1% | 0.00% | -100.0% |
| Q1 2022 | $8,227,000 | +401.6% | 1,116,230 | +338.0% | 0.00% | – |
| Q4 2021 | $1,640,000 | +19.4% | 254,868 | +8.0% | 0.00% | – |
| Q3 2021 | $1,373,000 | -43.5% | 235,915 | +0.2% | 0.00% | – |
| Q2 2021 | $2,429,000 | -7.0% | 235,428 | -5.1% | 0.00% | – |
| Q1 2021 | $2,611,000 | +1.2% | 248,183 | +48.9% | 0.00% | – |
| Q4 2020 | $2,581,000 | -1.7% | 166,714 | -7.3% | 0.00% | – |
| Q3 2020 | $2,625,000 | -7.1% | 179,821 | +20.5% | 0.00% | – |
| Q2 2020 | $2,825,000 | +42.7% | 149,180 | +44.8% | 0.00% | – |
| Q1 2020 | $1,979,000 | -12.4% | 102,997 | -12.6% | 0.00% | – |
| Q4 2019 | $2,258,000 | +290.0% | 117,821 | +96.1% | 0.00% | – |
| Q3 2019 | $579,000 | +77.6% | 60,094 | +10.4% | 0.00% | – |
| Q2 2019 | $326,000 | -22.6% | 54,428 | -24.3% | 0.00% | – |
| Q1 2019 | $421,000 | -24.4% | 71,928 | +21.0% | 0.00% | – |
| Q4 2018 | $557,000 | -53.8% | 59,432 | -16.0% | 0.00% | – |
| Q3 2018 | $1,205,000 | -7.2% | 70,739 | -7.5% | 0.00% | – |
| Q2 2018 | $1,299,000 | +115.8% | 76,448 | +70.3% | 0.00% | – |
| Q1 2018 | $602,000 | +47.5% | 44,892 | +5.5% | 0.00% | – |
| Q4 2017 | $408,000 | -31.4% | 42,559 | -21.3% | 0.00% | – |
| Q3 2017 | $595,000 | +47.6% | 54,100 | +21.3% | 0.00% | – |
| Q2 2017 | $403,000 | -31.9% | 44,602 | -3.3% | 0.00% | – |
| Q1 2017 | $592,000 | +37.4% | 46,127 | +0.7% | 0.00% | – |
| Q4 2016 | $431,000 | -3.4% | 45,819 | +0.0% | 0.00% | – |
| Q3 2016 | $446,000 | +15.8% | 45,804 | -20.1% | 0.00% | – |
| Q2 2016 | $385,000 | -25.1% | 57,304 | -0.6% | 0.00% | – |
| Q1 2016 | $514,000 | -46.8% | 57,676 | -21.0% | 0.00% | – |
| Q4 2015 | $967,000 | +19.5% | 72,986 | -4.9% | 0.00% | – |
| Q3 2015 | $809,000 | -76.3% | 76,786 | -38.7% | 0.00% | -100.0% |
| Q2 2015 | $3,411,000 | -25.1% | 125,360 | -15.7% | 0.00% | -50.0% |
| Q1 2015 | $4,555,000 | +213.9% | 148,792 | +283.8% | 0.00% | +100.0% |
| Q4 2014 | $1,451,000 | +148.5% | 38,765 | +131.9% | 0.00% | – |
| Q3 2014 | $584,000 | -21.2% | 16,718 | +5.0% | 0.00% | – |
| Q2 2014 | $741,000 | +0.3% | 15,924 | -33.5% | 0.00% | – |
| Q1 2014 | $739,000 | +2742.3% | 23,933 | +1973.9% | 0.00% | – |
| Q4 2013 | $26,000 | – | 1,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |